Loss of CtBP2 may be a mechanistic link between metabolic derangements and progressive impairment of pancreatic β cell function
Cell Reports · 2023
DOI: 10.1016/j.celrep.2023.112914 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Motohiro Sekiya und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan. Electroni…. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Islets of Langerhans, Obesity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The adaptive increase in insulin secretion in early stages of obesity serves as a safeguard mechanism to maintain glucose homeostasis that cannot be sustained, and the eventual decompensation of β cells is a key event in the pathogenesis of diabetes. Here we describe a crucial system orchestrated by a transcriptional cofactor CtBP2. In cultured β cells, insulin gene expression is coactivated by CtBP2. Global genomic mapping of CtBP2 binding sites identifies a key interaction between CtBP2 and NEUROD1 through which CtBP2 decompacts chromatin in the insulin gene promoter. CtBP2 expression is diminished in pancreatic islets in multiple mouse models of obesity, as well as human obesity. Pancreatic β cell-specific CtBP2-deficient mice manifest glucose intolerance with impaired insulin secretion. Our transcriptome analysis highlights an essential role of CtBP2 in the maintenance of β cell integrity. This system provides clues to the molecular basis in obesity and may be targetable to develop therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan. Electronic address: msekiya@md.tsukuba.ac.jp.
- Department of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.
- Department of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan; Transborder Medical Research Center, University of Tsukuba, Tsukuba 305-8575, I…
- Laboratory Animal Resource Center in Transborder Medical Research Center, University of Tsukuba, Tsukuba 305-8575, Ibaraki, Japan.
Zitieren
APA
Sekiya, M., Ma, Y., Kainoh, K., Saito, K., Yamazaki, D., Tsuyuzaki, T., Chen, W., Adi Putri, P. I. P., Ohno, H., Miyamoto, T., Takeuchi, Y., Murayama, Y., Sugano, Y., Osaki, Y., Iwasaki, H., Yahagi, N., Suzuki, H., Motomura, K., Matsuzaka, T., …, & Shimano, H. (2023). Loss of CtBP2 may be a mechanistic link between metabolic derangements and progressive impairment of pancreatic β cell function. Cell Reports. https://doi.org/10.1016/j.celrep.2023.112914
Vancouver
Sekiya M, Ma Y, Kainoh K, Saito K, Yamazaki D, Tsuyuzaki T, et al. Loss of CtBP2 may be a mechanistic link between metabolic derangements and progressive impairment of pancreatic β cell function. Cell Reports. 2023. doi:10.1016/j.celrep.2023.112914
BibTeX
@article{Sekiya2023,
author = {Sekiya, Motohiro and Ma, Yang and Kainoh, Kenta and Saito, Kenji and Yamazaki, Daichi and Tsuyuzaki, Tomomi and Chen, Wanpei and Adi Putri, Putu Indah Paramita and Ohno, Hiroshi and Miyamoto, Takafumi and Takeuchi, Yoshinori and Murayama, Yuki and Sugano, Yoko and Osaki, Yoshinori and Iwasaki, Hitoshi and Yahagi, Naoya and Suzuki, Hiroaki and Motomura, Kaori and Matsuzaka, Takashi and Murata, Kazuya and Mizuno, Seiya and Takahashi, Satoru and Shimano, Hitoshi},
title = {Loss of CtBP2 may be a mechanistic link between metabolic derangements and progressive impairment of pancreatic β cell function},
journal = {Cell Reports},
year = {2023},
doi = {10.1016/j.celrep.2023.112914}
}
EUVIMED